CORONA, CA, Mar 10, 2009 (MARKET WIRE via COMTEX) -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty
pharmaceutical company, announced today that Mark Durand, Watson's
senior vice president and chief financial officer, will provide an
overview and update of the Company's business at the Cowen and
Company 29th Annual Health Care Conference on Monday, March 16, 2009
at 2:25 p.m. Eastern Daylight Time.
This presentation will be webcast live and can be accessed on Watson
Pharmaceuticals' Investor Relations Web site at http://ir.watson.com.
The webcast can also be accessed at the following URL:
An archived version will be available for 90 days after the live
presentation and can be accessed at the same locations.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc. is a leading specialty pharmaceutical
company that develops, manufactures, markets, sells and distributes
generic and specialty brand pharmaceutical products. Watson pursues a
growth strategy combining internal product development, strategic
alliances and collaborations and synergistic acquisitions of products
For press releases and other company information, visit Watson
Pharmaceuticals' Web site at http://www.watson.com.
Watson Pharmaceuticals, Inc.
SOURCE: Watson Pharmaceuticals